Marie Thibault
Stock Analyst at BTIG
(4.11)
# 525
Out of 5,049 analysts
87
Total ratings
56.96%
Success rate
11.88%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DCTH Delcath Systems | Reiterates: Buy | $23 | $9.08 | +153.30% | 4 | Nov 4, 2025 | |
| DXCM DexCom | Maintains: Buy | $109 → $85 | $61.18 | +38.93% | 8 | Oct 31, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $195 → $215 | $181.10 | +18.72% | 8 | Oct 31, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $98.84 | +33.55% | 13 | Oct 22, 2025 | |
| TRUE TrueCar | Downgrades: Neutral | n/a | $2.19 | - | 1 | Oct 20, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $125.80 | +15.26% | 13 | Oct 15, 2025 | |
| MASI Masimo | Reiterates: Buy | $198 | $149.01 | +32.88% | 4 | Sep 11, 2025 | |
| EMBC Embecta | Reiterates: Buy | $25 | $13.52 | +84.91% | 3 | Sep 5, 2025 | |
| OBIO Orchestra BioMed Holdings | Downgrades: Neutral | n/a | $3.74 | - | 2 | Aug 20, 2025 | |
| ATRC AtriCure | Maintains: Buy | $58 → $52 | $32.75 | +58.78% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $270 | $320.27 | -15.70% | 4 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $49.40 | +31.58% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $112 | $50.38 | +122.31% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.86 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.11 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $1.38 | +407.25% | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.87 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.69 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $279.31 | -97.85% | 1 | Apr 9, 2020 |
Delcath Systems
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $9.08
Upside: +153.30%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $61.18
Upside: +38.93%
iRhythm Technologies
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $181.10
Upside: +18.72%
Boston Scientific
Oct 22, 2025
Reiterates: Buy
Price Target: $132
Current: $98.84
Upside: +33.55%
TrueCar
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Abbott Laboratories
Oct 15, 2025
Reiterates: Buy
Price Target: $145
Current: $125.80
Upside: +15.26%
Masimo
Sep 11, 2025
Reiterates: Buy
Price Target: $198
Current: $149.01
Upside: +32.88%
Embecta
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $13.52
Upside: +84.91%
Orchestra BioMed Holdings
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.74
Upside: -
AtriCure
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $32.75
Upside: +58.78%
Nov 8, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $320.27
Upside: -15.70%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $49.40
Upside: +31.58%
Sep 10, 2024
Initiates: Buy
Price Target: $112
Current: $50.38
Upside: +122.31%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.86
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.11
Upside: -
Jun 24, 2022
Maintains: Buy
Price Target: $9 → $7
Current: $1.38
Upside: +407.25%
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $2.87
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.69
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $279.31
Upside: -97.85%